Skip to search formSkip to main contentSkip to account menu

CI 922

Known as: CI-922, L-Arginine, compd. with 3,7-dimethoxy-4-phenyl-N-1H-tetrazol-5-yl-4H-furo(3,2-b)indole-2-carboxamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The present invention relates to a new portion of general formula (I), 3- (1H- tetrazol-5-yl) -4H- pyrido [1,2-a] and its… 
1988
1988
There is increasing evidence that activated neutrophils cause myocardial injury during reperfusion of ischemic myocardium. This… 
1987
1987
The allergic mediator release inhibitor 3,7‐dimethoxy‐4‐phenyl‐N‐1H‐tetrazol‐5‐yl‐4H‐furo[3,2‐b]indole‐2‐carboxamide, L‐arginate… 
1986
1986
An automated liquid chromatographic assay using unattended robotic sample preparation has been developed and validated to… 
1986
1986
The allergic mediator release inhibitor CI-922 (3,7-dimethoxy-4-phenyl-N-1H-tetrazol-5-yl-4H-furo(3,2-b)indole-2-carboxamide) is… 
1986
1986
CI-922 (3,7-dimethoxy-4-phenyl-N-1H-tetrazol-5-yl-4H-furo[3,2-b]indole-2-carboxamide, 1,2-ethanediamine, 2∶1), an antiallergy… 
1985
1985
We report differential effects of various compounds on inhibition of histamine release from washed leukocytes stimulated through…